Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026

$3,850.00$5,850.00

Published on: April 1, 2021
Clear
SKU: GMS-1309 Category:

OVERVIEW

The study predicts the short-term and long-term trends that can shape the future of orthobiologics market size that is expected to surpass USD 6.26 million by 2026 growing at a CAGR of 5.4 percent over the forecast period and this report will also account for Covid-19 implications as it acts as a key market contributor. Major factors contributing to the expansion of the worldwide market include the increase in the cases of trauma and sports injury, and demand for biologics in minimally evasive procedures.

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 1

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 2

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 3

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 4

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 5

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 6

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 7

Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 8
Orthobiologics Market by Application (Osteoarthritis, Spinal Fusion, Fracture Recovery, Soft Tissue), by Product (Synthetic Orthobiologics, Viscosupplementation, PRP, BMAC, Allograft, DBM, BMP), End User (Academia, Hospitals, ASCs) – 2021 to 2026 7

TABLE OF CONTENT

1 Global Orthobiologics Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Orthobiologics Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Orthobiologics Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Orthobiologics Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Orthobiologics Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Orthobiologics Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Orthobiologics Market – By Product (Market Size – & million/billion)
8.1 Viscosupplementation Products
8.2 DBM
8.3 Synthetic Orthobiologics
8.4 BMP
8.5 Allografts
8.6 PRP
8.7 BMAC

9 Global Orthobiologics Market – By Application
9.1 Osteoarthritis and Degenerative Arthritis
9.2 Spinal Fusion
9.3 Fracture Recovery
9.4 Soft Tissue Injuries
9.5 Maxillofacial and Dental Applications

10 Global Orthobiologics Market – By End-User
10.1 Hospitals, Orthopedic Clinics, and Ambulatory Care Centers
10.2 Research and Academic Institutes
10.3 Dental Clinics and Facilities

11 Global Orthobiologics Market – By Geography (Market Size – & million/billion)
11.1 Introduction
11.2 North America
11.2.1 US
11.2.2 Canada
11.2.3 Mexico
11.3 Europe
11.3.1 U.K
11.3.2 Germany
11.3.3 Italy
11.3.4 France
11.3.5 Spain
11.3.6 Rest of Europe
11.4 Asia-Pacific
11.4.1 China
11.4.2 Japan
11.4.3 India
11.4.4 South Korea
11.4.5 Rest of APAC
11.5 Rest of the World
11.5.1 South America
11.5.2 Middle East
11.5.3 Africa

12 Global Orthobiologics Market – Entropy
12.1 New product launches
12.2 M&A’s, collaborations, JVs and partnerships

13 Global Orthobiologics Market Company Profile (Key Players)
13.1 Market Share, Company Revenue, Products, M&A, Developments
13.2 Harvest Technologies Corporation (A Terumo Bct Company)
13.3 Zimmer Biomet Holdings, Inc.
13.4 Medtronic PLC.
13.5 Stryker Corporation
13.6 Depuy Synthes
13.7 Bioventus LLC
13.8 Kuros Biosciences Ltd.
13.9 K2M Group Holdings, Inc.
13.10 Orthofix International N.V.
13.11 RTI Surgical, Inc.
13.12 Company 11 & more

14 Global Orthobiologics Market – Appendix
14.1 Sources
14.2 Abbreviations